• Bufalin & CRISPR-Cas9 Nanomedicine: Remodeling CRC Immunity

  2026-06-14

  This study introduces a calcium lactate nanoparticle system co-delivering bufalin and CRISPR/Cas9 RNPs to target both tumor cell death and immune microenvironment modulation in colorectal cancer. By inducing pyroptosis and macrophage reprogramming, the approach demonstrates a synergistic strategy to enhance immunotherapy efficacy and offers new directions for tackling CRC treatment resistance.

• TRIM21-ERK1/2 Axis Drives Proliferation and Drug Resistance

  2026-06-13

  The reference study uncovers how TRIM21 promotes pituitary adenoma cell proliferation and drug resistance via ERK1/2 ubiquitination and phosphorylation. It also identifies Quisinostat (JNJ-26481585) as an effective HDAC inhibitor for reducing TRIM21 protein levels, suggesting new strategies for overcoming therapeutic resistance in pituitary tumors.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–Receptor Bindi

  2026-06-12

  Oliveira et al. (2025) reveal that naturally occurring angiotensin peptides, especially shorter fragments, significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor, and in some cases to ACE2 and NRP1. These findings provide new molecular insights connecting the renin-angiotensin system with COVID-19 pathogenesis, informing future cardiovascular and infectious disease research models.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Pr

  2026-06-12

  DiI (DiIC18(3)) is a lipophilic orange fluorescent probe designed for robust plasma membrane labeling in live and fixed biological samples. It solves challenges in neuronal tracing and cell migration assays where aqueous dyes fail but is not suitable for intracellular or organelle-specific staining, or for workflows requiring water solubility.

• Minocycline HCl in Scalable EV Production & Neuroinflammatio

  2026-06-11

  Minocycline HCl empowers researchers to bridge antimicrobial, anti-inflammatory, and neuroprotective workflows—now proven essential for scalable, reproducible extracellular vesicle (EV) research. Learn the latest protocol enhancements, troubleshooting strategies, and translational advantages that make APExBIO's Minocycline HCl the reagent of choice for cutting-edge neuroinflammation and regenerative medicine.

• Z-WEHD-FMK: Illuminating Caspase-1/4/5 in Pyroptosis & Infla

  2026-06-11

  Explore how Z-WEHD-FMK, a potent irreversible caspase inhibitor, advances inflammation research and unravels the caspase signaling pathway's role in pyroptosis. This article offers new insights into assay design and practical applications beyond current literature.

• Biotin (Vitamin B7): Advanced Protein Labeling and Metabolic

  2026-06-10

  Biotin (Vitamin B7) is not only a metabolic coenzyme but a pivotal reagent for precise protein labeling and high-fidelity biochemical workflows. This guide demystifies applied uses, stepwise protocols, and troubleshooting, translating leading research and APExBIO’s high-purity product into actionable laboratory success.

• 3-(1-methylpyrrolidin-2-yl)pyridine (N2703): Transforming Mo

  2026-06-10

  3-(1-methylpyrrolidin-2-yl)pyridine (N2703) is rapidly establishing itself as an indispensable investigational tool for dissecting cellular signaling pathways. Its high solubility, purity, and ability to modulate protein interactions enable robust, reproducible workflows across both in vitro and in vivo models—empowering new insights into molecular mechanisms underlying health and disease.

• GSK343: Precision EZH2 Inhibitor Workflows for Cancer Resear

  2026-06-09

  Unlock robust, reproducible insights with GSK343—a potent, SAM-competitive EZH2 inhibitor tailored for dissecting histone methylation and gene repression in cancer models. This article delivers actionable workflow enhancements, troubleshooting tips, and a translational perspective from the latest stem cell epigenetics research.

• Targeted EPO mRNA Nanoparticles Suppress Ferroptosis in SCI

  2026-06-09

  This study introduces a mannose-modified lipid nanoparticle system for delivering human erythropoietin (EPO) mRNA directly to inflammatory macrophages in spinal cord injury (SCI). By enabling local EPO expression, the strategy attenuates neuroinflammation and ferroptosis, representing a promising advance for mRNA-based neurorepair.

• Reserpine (SKU N1867): Technical Guide for Lab Research Work

  2026-06-08

  Reserpine, a high-purity alkaloid sourced from Rauvolfia plants, is routinely used in neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology workflows. This guide details product-specific handling, protocol optimization, and boundaries for its use in research—excluding diagnostic or clinical applications.

• Ibrexafungerp Activity Against Candida at Vaginal pH: In Vit

  2026-06-08

  The referenced study demonstrates that ibrexafungerp (MK 3118) retains potent antifungal activity against both fluconazole-susceptible and resistant Candida isolates from vulvovaginal candidiasis (VVC), even under acidic conditions mimicking the vaginal environment. These findings address a critical limitation of traditional azole antifungals and inform protocol selection for antifungal susceptibility testing and translational research.

• Biomimetic Chromatography for Lung Drug Permeability Modelin

  2026-06-07

  This study systematically benchmarks biomimetic open tubular capillary electrochromatography (OT-CEC) and immobilised artificial membrane chromatography (IAM-LC), each coupled with mass spectrometry, for predicting pulmonary drug permeability. The findings provide a robust, high-throughput platform to inform respiratory drug development and the optimization of anti-inflammatory corticosteroids such as Budesonide.

• Optimizing Cell Assays with T0070907: Precision PPARγ Antago

  2026-06-06

  This article addresses real-world challenges in cell viability and pathway research, demonstrating how T0070907 (SKU A4301) enables reproducible, high-sensitivity assays for PPARγ function. By integrating scenario-driven Q&A and evidence-based protocol advice, it supports researchers seeking reliable, cost-effective solutions for adipogenesis, cancer, and inflammation studies.

• MLKL Polymerization Triggers Lysosomal Permeabilization in N

  2026-06-05

  This study establishes a mechanistic link between MLKL polymerization and lysosomal membrane permeabilization (LMP) as a pivotal event in necroptosis execution. By demonstrating that MLKL polymers induce LMP and subsequent cathepsin-mediated cell death, it advances our understanding of regulated necrotic pathways and highlights new experimental angles for cell death research.

456 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page